ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026
– Updated data across two dose levels of 200 mW/cm and 400…
Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings
May 29, 2026 21:18 ET | Source: Fobi AI Inc. VANCOUVER, BC,…
Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00
MONACO, May 29, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning…
Cash and Gift Cards Dominate Consumer Reward Preferences: Kashkick Survey of 224,000+ Aligns With $507B U.S. Gift Card Market
New Kashkick data finds 54.14% of consumers rank cash as the #1…
XCMG Secures Over $1 Billion in Orders at 8th International Customer Festival, Expanding Global Partnerships
XUZHOU, China, May 29, 2026 /PRNewswire/ -- XCMG concluded its 8th International…
Hyundai Motor Launches “School of Football” Campaign Featuring Boston Dynamics’ Atlas Ahead of FIFA World Cup 2026
New five-part social film series follows Atlas' journey to learn football (soccer)…
Alibaug: The Rise of Mumbai’s Premium Coastal Market
Alibaug Land Values Projected to Appreciate Up to 3.5x Over the Next…
Kane Biotech Announces Grant of Stock Options
Not for distribution to U.S. news wire services or dissemination in the…
Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis
May 29, 2026 17:00 ET | Source: Quest PharmaTech Inc. EDMONTON, Alberta,…
Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy
May 29, 2026 16:05 ET | Source: Jade Biosciences SAN FRANCISCO and…
